A novel non-integrative single-cycle chimeric HIV lentivector DNA vaccine
- PMID: 25825333
- DOI: 10.1016/j.vaccine.2015.03.021
A novel non-integrative single-cycle chimeric HIV lentivector DNA vaccine
Abstract
Novel HIV vaccine vectors and strategies are needed to control HIV/AIDS epidemic in humans and eradicate the infection. DNA vaccines alone failed to induce immune responses robust enough to control HIV-1. Development of lentivirus-based DNA vaccines deficient for integration and with a limited replication capacity is an innovative and promising approach. This type of vaccine mimics the early stages of virus infection/replication like the live-attenuated viruses but lacks the inconvenient integration and persistence associated with disease. We developed a novel lentivector DNA vaccine "CAL-SHIV-IN(-)" that undergoes a single round of replication in the absence of integration resulting in augmented expression of vaccine antigens in vivo. Vaccine gene expression is under control of the LTRs of a naturally attenuated lentivirus, Caprine arthritis encephalitis virus (CAEV) the natural goat lentivirus. The safety of this vaccine prototype was increased by the removal of the integrase coding sequences from the pol gene. We examined the functional properties of this lentivector DNA in cell culture and the immunogenicity in mouse models. Viral proteins were expressed in transfected cells, assembled into viral particles that were able to transduce once target permissive cells. Unlike the parental replication-competent SHIV-KU2 that was detected in DNA samples from any of the serial passage infected cells, CAL-SHIV-IN(-) DNA was detected only in target cells of the first round of infection, hence demonstrating the single cycle replication of the vaccine. A single dose DNA immunization of humanized NOD/SCID/β2 mice showed a substantial increase of IFN-γ-ELISPOT in splenocytes compared to the former replication and integration defective Δ4SHIV-KU2 DNA vaccine.
Keywords: Antibodies; CAEV; DNA vaccine; Lentivector; SHIV; T cells.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Immunogenicity of a lentiviral-based DNA vaccine driven by the 5'LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques.Vaccine. 2012 Apr 19;30(19):2956-62. doi: 10.1016/j.vaccine.2012.02.050. Epub 2012 Mar 2. Vaccine. 2012. PMID: 22387218 Free PMC article.
-
HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.AIDS. 2015 Mar 27;29(6):649-58. doi: 10.1097/QAD.0000000000000595. AIDS. 2015. PMID: 25849828
-
Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV-1 polyepitope CTL immunogen.Microb Biotechnol. 2012 Mar;5(2):241-50. doi: 10.1111/j.1751-7915.2011.00291.x. Epub 2011 Sep 6. Microb Biotechnol. 2012. PMID: 21895998 Free PMC article.
-
Prime-boost strategies in DNA vaccines.Methods Mol Med. 2006;127:171-97. doi: 10.1385/1-59745-168-1:171. Methods Mol Med. 2006. PMID: 16988455 Review.
-
Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.AIDS Res Hum Retroviruses. 2015 Nov;31(11):1077-88. doi: 10.1089/AID.2015.0101. Epub 2015 Aug 13. AIDS Res Hum Retroviruses. 2015. PMID: 26149745 Review.
Cited by
-
Towards the Generation of an ASFV-pA104R DISC Mutant and a Complementary Cell Line-A Potential Methodology for the Production of a Vaccine Candidate.Vaccines (Basel). 2019 Jul 18;7(3):68. doi: 10.3390/vaccines7030068. Vaccines (Basel). 2019. PMID: 31323824 Free PMC article.
-
A DNA inducing VLP vaccine designed for HIV and tested in mice.PLoS One. 2017 Aug 24;12(8):e0183803. doi: 10.1371/journal.pone.0183803. eCollection 2017. PLoS One. 2017. Retraction in: PLoS One. 2018 Aug 31;13(8):e0203635. doi: 10.1371/journal.pone.0203635. PMID: 28837706 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources